Keywords
cost
drug therapy
drug prescriptions
hypoglycemic agents
Colombia
How to Cite
Abstract
Background: The consumption of antidiabetic drugs at seven measured by the increase in the number of dispensations and the cost associated with these consumptions.
Purpose: To describe the changes in pharmacological therapies and determine the variations in the per capita cost of antidiabetic drugs in Colombia.
Methodology: Through the observation of an open population cohort in which dispensing of antidiabetic drugs began between June 1, 2015 and June 30, 2017, with follow-up until May 2021 (2 years); the sociodemographic characteristics of the population were described, and the variations between the initial and final treatment were analyzed. Comparisons by sex and affiliation regime were made. SPSS was used for the descriptive analysis.
Results: The analyzed cohort had 11,782 patients, 56% men, with a higher concentration of the population (70%) in the range of 50 to 74 years. The cost per patient found at the end of follow-up was $108,271 (Colombian pesos, COP). There is a considerable increase in the per capita cost of $83,214 (COP) during the analysis period.
Conclusions: The costs of pharmacological treatment of diabetic patients generate a high economic burden for the Colombian health system.
References
Asociación Latinoamericana de Diabetes. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia. Rev ALAD [Internet]. 2019. https://www.revistaalad.com/guias/5600AX191_guias_alad_2019.pdf
International Diabetes Federation. IDF Diabetes Atlas [Internet]. 2021. www.diabetesatlas.org
Cuenta de Alto Costo. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2020 [Internet]. 2020. https://cuentadealtocosto.org/site/wp-content/uploads/2021/07/CAC.Co_2021_07_14_Libro_Sit_ERC2020_v4(1).pdf
Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers. J Glob Health. 2017;7(2). https://doi.org/10.7189/jogh.07.020410
Association AD. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care. 2021 jun. 16;44(supl. 1):s15-33. https://doi.org/10.2337/dc21-S002
Ministerio de Salud y Protección Social. Ley 8430 de 1993 [Internet]. 2021. https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%205857%20de%202018.pdf
Machado JE, Moncada JC, Mesa G. Patrones de prescripción de antidiabéticos en un grupo de pacientes colombianos. Rev Panam Salud Pública. 2007;22(2). https://doi.org/10.1590/S1020-49892007000700007
Villegas-Perrasse A, Abad SB, Faciolince S, Hernández N, Maya C, Parra L, et al. El control de la diabetes mellitus y sus complicaciones en Medellín, Colombia, 2001-2003. Rev Panam Salud Pública. 2006 dic.;20(6):393-402. https://doi.org/10.1590/S1020-49892006001100005
Barengo N, Camacho S, López PA, Camacho PA, García ÁA, Hincapié JA, et al. Patrones de prescripción de medicamentos para la diabetes mellitus tipo 2 en cinco departamentos de Colombia, en 2014. 2018;36(2):58-65. https://doi.org/10.17533/udea.rfnsp.v36n2a08
Ministerio de Salud y Protección Social. Resolución No. 5857 de 2018: “Por la cual se actualiza integralmente el Plan de Beneficios en Salud con cargo a la Unidad de Pago por Capitación (UPC)”. Diario Oficial No. 50.818. https://www.icbf.gov.co/cargues/avance/docs/resolucion_minsaludps_5857_2018.htm
Vargas-Uricoechea H, Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Ann Glob Heal. 2015 nov. 1;81(6):742-53. https://doi.org/10.1016/j.aogh.2015.11.001
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo